Kidney Transplant; Complications Clinical Trial
Official title:
Implication of Serum Fluoride Level Caused by Sevoflurane Versus Isoflurane Anesthesia Upon Renal Function After Kidney Transplantation.
Our primary goal is to investigate any hidden burden upon the grafted kidney from the increase of serum fluoride resulted from sevoflurane, versus isoflurane.
Eighty patients with end stage renal failure undergoing living donor kidney transplant under
general anesthesia were included in this study, by using an open (non-blinded) study design,
patients were randomly assigned to two groups, 15 patients in each. Randomization was done
through computer generated random tables. Isoflurane group; anesthesia was maintained with
isoflurane 1-2%. Sevoflurane group; anesthesia was maintained with Sevoflurane 1-2%.
A peripheral intravenous access was secured in the hand opposite to the functioning fistula
and induction of anesthesia was done with propofol 2mg/kg, neuromuscular blockade was
maintained with atracurium 0.6mg/kg and all patients were intubated and ventilated to
maintain end-tidal carbon dioxide (ETCO2) concentration between 30-40 mmHg. Anaesthesia was
maintained with 1-2% isoflurane (isoflurane group) or 1-2% sevoflurane (sevoflurane group)
with fresh gas flow of 2 L/min. In both groups inhalational anesthetic was delivered in an
air-oxygen mixture of 1:1 ratio. Analgesia was maintained with fentanyl 1µg/kg/hr. Mannitol
and sodium bicarbonate was given immediately before reperfusion (de-clamping of renal
artery). Intraoperative monitoring included heart rate, noninvasive blood pressure, oxygen
saturation, ETCO2, ECG and central venous line was placed in the right or left internal
jugular vein depending upon the presence of dialysis catheter. Hemodynamic target include:
mean arterial pressure of > 80mmHg, CVP between 10-15 mm Hg to optimize cardiac output and
renal blood flow.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04369456 -
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
|
N/A | |
| Recruiting |
NCT06001320 -
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
|
Early Phase 1 | |
| Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
| Not yet recruiting |
NCT05782543 -
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
|
N/A | |
| Completed |
NCT03996551 -
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
|
N/A | |
| Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
| Recruiting |
NCT04508907 -
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
|
Phase 4 | |
| Recruiting |
NCT06440330 -
Define Predictors for Posttransplant Diabetes Mellitus Study
|
||
| Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
| Recruiting |
NCT04713774 -
Bone Density and Vascular Calcifications Evolution After Renal Transplant
|
||
| Active, not recruiting |
NCT05483725 -
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
|
||
| Recruiting |
NCT06095492 -
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
|
N/A | |
| Active, not recruiting |
NCT04207177 -
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
|
Phase 4 | |
| Recruiting |
NCT03410654 -
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
|
Early Phase 1 | |
| Completed |
NCT04835948 -
Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation
|
||
| Not yet recruiting |
NCT04514666 -
VOCs in Kidney and Liver Transplants
|
N/A | |
| Recruiting |
NCT03373500 -
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
|
N/A | |
| Recruiting |
NCT05900401 -
Delayed Tolerance Through Mixed Chimerism
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05166460 -
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation
|
N/A | |
| Recruiting |
NCT05977387 -
Pediatric Kidney Transplant
|